Vivos Therapeutics, Inc. (VVOS)
USD 4.54
(-7.35%)
USD 4.54
(-7.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -11.94 Million | -19.58 Million | -15.73 Million | -5.68 Million | -5.34 Million | -5.31 Million |
| Net Income | -13.58 Million | -23.84 Million | -20.28 Million | -12.05 Million | -10.75 Million | -8.43 Million |
| Depreciation & Amortization | 621 Thousand | 669 Thousand | 733 Thousand | 717.86 Thousand | 751.22 Thousand | 610.67 Thousand |
| Deferred income taxes | -1.35 Million | - | 1.14 Million | - | 60.34 Thousand | - |
| Stock-based compensation | 1.1 Million | 2.39 Million | 2.65 Million | 2.17 Million | 1.98 Million | 1.28 Million |
| Change in working capital | 2.86 Million | 1.71 Million | 28 Thousand | -431.07 Thousand | 2.53 Million | 867.09 Thousand |
| Other non-cash items | -1.59 Million | -518 Thousand | -9000.00 | 3.91 Million | 83.06 Thousand | 364.33 Thousand |
| Investing Cash Flow | -853 Thousand | -924 Thousand | -2.6 Million | -120.25 Thousand | 86.22 Thousand | -1.11 Million |
| Investments in PPE | -853 Thousand | -924 Thousand | -2.39 Million | -120.25 Thousand | -175.59 Thousand | -1.25 Million |
| Acquisitions | - | - | -225 Thousand | - | 250 Thousand | 133.33 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -50 Thousand | -924 Thousand | 13 Thousand | -120.25 Thousand | 11.82 Thousand | - |
| Financing Cash Flow | 10.92 Million | - | 24.16 Million | 23.53 Million | 4.46 Million | 5.25 Million |
| Debt repayment | - | - | -25 Thousand | -75 Thousand | -29.26 Thousand | -88.23 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -1.5 Million | -2.15 Million | -350 Thousand | -1 Million |
| Common Stock Issuance | 12 Million | - | 25.69 Million | 22.28 Million | 1.24 Million | 6.35 Million |
| Other Financing Activities | -1.07 Million | - | 24.19 Million | 7.18 Million | 7.35 Million | -12.46 Thousand |
| Accounts receivables | 255 Thousand | 746 Thousand | 228 Thousand | -559.6 Thousand | -276.1 Thousand | -530.28 Thousand |
| Accounts payables | 734 Thousand | 491 Thousand | 139 Thousand | -274.21 Thousand | 547.62 Thousand | 246.53 Thousand |
| Inventory | - | - | 168 Thousand | 332.59 Thousand | 401.01 Thousand | - |
| Other working capital | 1.87 Million | 474 Thousand | -507 Thousand | 70.14 Thousand | 1.85 Million | 1.15 Million |
| Cash at beginning of period | 3.51 Million | 24.03 Million | 18.2 Million | 469.35 Thousand | 1.25 Million | 2.43 Million |
| Cash at end of period | 1.64 Million | 3.51 Million | 24.03 Million | 18.2 Million | 469.35 Thousand | 1.25 Million |
| Capital Expenditure | -853 Thousand | -924 Thousand | -2.39 Million | -120.25 Thousand | -175.59 Thousand | -1.25 Million |
| Effect of forex changes on cash | 11.94 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -1.87 Million | -20.51 Million | 5.82 Million | 17.73 Million | -785.37 Thousand | -1.17 Million |
| Free Cash Flow | -12.79 Million | -20.51 Million | -18.13 Million | -5.8 Million | -5.51 Million | -6.56 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.93 Million | -3.76 Million | -13.58 Million | -4.25 Million | -2.09 Million | -5.52 Million |
| Depreciation & Amortization | 145 Thousand | 146 Thousand | 621 Thousand | 149 Thousand | 149 Thousand | 148 Thousand |
| Deferred income taxes | - | - | -1.35 Million | 192 Thousand | - | -5.94 Million |
| Stock-based compensation | 270 Thousand | 293 Thousand | 1.1 Million | 152 Thousand | 189 Thousand | 459 Thousand |
| Change in working capital | -1.55 Million | 802 Thousand | 2.86 Million | 906 Thousand | 713 Thousand | 1.01 Million |
| Other non-cash items | 926 Thousand | 561 Thousand | -1.59 Million | 112 Thousand | -1.75 Million | 6.99 Million |
| Investing Cash Flow | -60 Thousand | -151 Thousand | -853 Thousand | -165 Thousand | -154 Thousand | -245 Thousand |
| Investments in PPE | -60 Thousand | -151 Thousand | -853 Thousand | -165 Thousand | -154 Thousand | -245 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -151 Thousand | -50 Thousand | -803 Thousand | - | - |
| Financing Cash Flow | 7.4 Million | 3.63 Million | 10.92 Million | 3.56 Million | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -116 Thousand | - | - |
| Common Stock Issuance | 7.4 Million | 3.63 Million | 12 Million | 4 Million | - | - |
| Other Financing Activities | -100 Thousand | -306 Thousand | -1.07 Million | -432 Thousand | - | - |
| Accounts receivables | 131 Thousand | -324 Thousand | 255 Thousand | 26 Thousand | 99 Thousand | -6000.00 |
| Accounts payables | -471 Thousand | 354 Thousand | 734 Thousand | 616 Thousand | 204 Thousand | -170 Thousand |
| Inventory | - | - | - | -662 Thousand | -801 Thousand | 1.46 Million |
| Other working capital | -1.21 Million | 772 Thousand | 1.87 Million | 264 Thousand | 1.21 Million | -275 Thousand |
| Cash at beginning of period | 2.61 Million | 1.64 Million | 3.51 Million | 988 Thousand | 3.94 Million | 7.04 Million |
| Cash at end of period | 6.9 Million | 2.61 Million | 1.64 Million | 1.64 Million | 988 Thousand | 3.94 Million |
| Capital Expenditure | -60 Thousand | -151 Thousand | -853 Thousand | -165 Thousand | -154 Thousand | -245 Thousand |
| Effect of forex changes on cash | - | - | 11.94 Million | - | - | - |
| Net cash flow / Change in cash | 4.29 Million | 968 Thousand | -1.87 Million | 655 Thousand | -2.95 Million | -3.1 Million |
| Free Cash Flow | -3.1 Million | -2.66 Million | -12.79 Million | -2.91 Million | -2.95 Million | -3.1 Million |
ECXJ
KMDA
KTMS
ELRA
TAND
AIIL